Number of Shares
1.60 Mil
Current Holdings Value*
$1.32 Bil
% of Portfolio
11.6%
Total Estimate Gain
$1.25 Bil
% of Total Estimate Gain
225.66%

T. Rowe Price Health Sciences Fund, Inc.'s Eli Lilly and Co Holding Summary

As of 2025-03-31, T. Rowe Price Health Sciences Fund, Inc. held 1.60 Mil shares of Eli Lilly and Co(LLY), totaling $1.32 Bil. This investment constitutes 11.6% of their stock portfolio, and T. Rowe Price Health Sciences Fund, Inc. now holds 0.18% of the outstanding Eli Lilly and Co(LLY) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price Health Sciences Fund, Inc. has made 3 purchases of LLY, at an average price of $222.91, for a total of 2.49 Mil shares. In addition, there have been 9 sales at an average price of $594.88 for 889,673.00 shares. Based on historical transaction data and LLY's current price of $798.85, T. Rowe Price Health Sciences Fund, Inc.'s estimated gain on his LLY holdings is $1.25 Bil, reflecting a 225.66% gain to date.

T. Rowe Price Health Sciences Fund, Inc. LLY ($798.85) Holding Chart

T. Rowe Price Health Sciences Fund, Inc. LLY ($798.85) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1